Last updated: 4 months ago
AstraZeneca's Oncology Report: Challenges & Innovations in Lung Cancer Treatments
Explore AstraZeneca's recent MAA withdrawal for datopotamab deruxtecan, ongoing trials, and strategies in advancing lung cancer therapies.
Posts With Tag antibody-drug conjugate
Showing 1 - 1 of 1 Post